These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5133987)

  • 21. L-Dopa therapy in Parkinson's disease.
    Greer M
    J Fla Med Assoc; 1970 Jun; 57(6):23-7. PubMed ID: 4392779
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa].
    Fieschi C; Casacchia M; Nardini M; Reitano N
    Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075
    [No Abstract]   [Full Text] [Related]  

  • 23. [Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa?].
    Gauthier G; de Ajuriaguerra J; Geissbuhler F; Simona B; Constantinidis J; Yanniotis G; Krassoievitch M; Eisenring JJ; Tissot R
    Presse Med (1893); 1971 Jan; 79(3):91-2. PubMed ID: 5539694
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of L-DOPA on the akinesis in Parkinson's syndrome].
    Bischoff A
    Schweiz Med Wochenschr; 1967 Sep; 97(35):1158-9. PubMed ID: 5593650
    [No Abstract]   [Full Text] [Related]  

  • 25. [Preliminary observations on the use of L-DOPA in the treatment of the akinetic symptoms of Parkinson's disease].
    Uriciuoli R; Nivoli GC
    Minerva Med; 1968 May; 59(43):2516-21. PubMed ID: 5664430
    [No Abstract]   [Full Text] [Related]  

  • 26. L-dopa for Parkinson's disease; some limitations in its use.
    Gillen HW
    Med Trial Tech Q; 1973; 19(4):400-8. PubMed ID: 4710961
    [No Abstract]   [Full Text] [Related]  

  • 27. [L-Dopa in the treatment of Parkinson's disease].
    Warot P
    Lille Med; 1971; 17():Suppl:329-34. PubMed ID: 5153001
    [No Abstract]   [Full Text] [Related]  

  • 28. [The treatment of Parkinson's disease with L-dopa].
    Dalle Ore G; Bricolo A; Robotti E; Bazzan A; Mazza C
    Policlinico Prat; 1970 Apr; 77(16):509-24. PubMed ID: 5443873
    [No Abstract]   [Full Text] [Related]  

  • 29. [The trial of intravenous L-DOPA in patients with Parkinson's disease].
    Nardini M; Fieschi C; Agnoli A; Arcioli I; Zanette E
    Riv Neurol; 1970; 40(2):75-85. PubMed ID: 5429003
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of L-dopa treatment on the speech of patients with Parkinson's disease.
    Audelman JU; Hoel RL; Lassman FM
    Neurology; 1970 Apr; 20(4):410-1. PubMed ID: 5535064
    [No Abstract]   [Full Text] [Related]  

  • 31. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases].
    Herskovits E; Matera R; Gacitua EF
    Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes in saccadic eye movements of patients with Parkinson's disease before and after L-dopa.
    Highstein S; Cohen B; Mones R
    Trans Am Neurol Assoc; 1969; 94():277-9. PubMed ID: 5374461
    [No Abstract]   [Full Text] [Related]  

  • 33. [The therapeutic association of L-dopa and amantadine. Preliminary results in a group of patients with Parkinson's disease].
    Gomirato G; Perfetti C
    Riv Neurobiol; 1970; 16(3):247-54. PubMed ID: 5518838
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy of Parkinson's syndrome with L-dopa only and in combination with a decarboxylase inhibitor. A comparison].
    Feise G; Paal G
    Nervenarzt; 1974 Mar; 45(3):126-32. PubMed ID: 4832035
    [No Abstract]   [Full Text] [Related]  

  • 35. [L-dopa in the treatment of Parkinson's disease. Preliminary report].
    Poch GF
    Prensa Med Argent; 1969 Oct; 56(34):1629-32. PubMed ID: 5405572
    [No Abstract]   [Full Text] [Related]  

  • 36. [L-dopa effect in Parkinson's syndrome].
    Römer F; Bettag W; Bock WJ
    Z Allgemeinmed; 1971 Feb; 47(6):281-3. PubMed ID: 5571715
    [No Abstract]   [Full Text] [Related]  

  • 37. [The treatment of Parkinson's syndrome with L-dopa].
    Völler GW; Kerstan J
    Nervenarzt; 1970 Mar; 41(3):138-44. PubMed ID: 5447886
    [No Abstract]   [Full Text] [Related]  

  • 38. [L-dopa and Parkinson's disease].
    Barbeau A
    Union Med Can; 1970 Dec; 99(12):2195-7. PubMed ID: 5488646
    [No Abstract]   [Full Text] [Related]  

  • 39. [L-Dopa in Parkinson's-syndrome. New therapeutic attack?].
    Brockmann AW
    Ther Ggw; 1970 Nov; 109(11):1590-3. PubMed ID: 5486128
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's disease.
    Van Woert MH
    Conn Med; 1970 Jun; 34(6):401-5. PubMed ID: 5431103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.